4-18-22: Shiraz, Iran: "the patients receiving favipiravir or Kaletra had significantly shorter hospital stays than those receiving IFN-β...favipiravir (70%), remdesivir (30%), and Kaletra (50%) reduced mortality compared to IFN-β" https://t.co/RfHQLQpSoY
そういやあ、世界に効かない認定されて忘れ去られたファビピラビル（アビガン）だけども、中国の試験ではそんなに悪くない結果を出していたんだよな。https://t.co/6Ln2fPQrli
7-11-2022: Shinzo Abe will be remembered for many things, including the offering of free favipiravir tablets in 2020 to all nations: https://t.co/RfHQLQ7JaQ https://t.co/TGngCcCo0g https://t.co/vBRxxhtx1b https://t.co/rjuQWPGuk6 https://t.co/32Waf4wA4a ht
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study https://t.co/3a76Fdnj3U